Temasek acquire 5pc stake in Evonik $780 million

Temasek to acquire 5pc stake in Evonik for $780 million

9:53 AM, 11th March 2013
Temasek to acquire 5pc stake in Evonik for $780 million

SINGAPORE/ESSEN, GERMANY: Singapore state investor Temasek Holdings will take a stake in Evonik Industries. Temasek will spend more than €600 million ($780 million) for 5 per cent of the Essen-based chemicals company, which is preparing for a stock market share listing.

© WOC News

0 Comments

Login

Your Comments (Up to 2000 characters)
Please respect our community and the integrity of its participants. WOC reserves the right to moderate and approve your comment.

Related News


Total restarts production at Elgin/Franklin gas fields

PARIS, FRANCE: Total announced the restart of production on the Elgin/Franklin area on 9 March 2013, following the approval of the safety case by th ...

Read more
Linde to build six major air separation units for Chinese firm

MUNICH, GERMANY: The technology company, The Linde Group, will build six major air separation units for Shenhua Ningxia Coal Industry Group Co Ltd and ...

Read more
Enterprise expands LPG export facility in Houston, US

HOUSTON, US: Enterprise Products Partners LP has commenced operations at its expanded export facility, increasing the partnership’s capability ...

Read more
Behind every smile there is chemistry

  SINGAPORE: Many people do not realize the power of a smile. A smile can work magic, it can heal emotional pain, and it can remove physical pai ...

Read more
New AFM-IR technique to measure chemical properties of polymer nanostructures

ILLINOIS, US: For more than 20 years, researchers have been using atomic force microscopy (AFM) to measure and characterize materials at the nanometre ...

Read more
ADA-ES bags activated carbon injection contract for two coal power plants

HIGHLANDS RANCH, US: ADA-ES Inc has been awarded a contract from a large air pollution equipment company to supply activated carbon injection (ACI) an ...

Read more
www.worldofchemicals.com uses cookies to ensure that we give you the best experience on our website. By using this site, you agree to our Privacy Policy and our Terms of Use. X